Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers

Journal of Controlled Release

Volumn 164, Issue 3, 2012, Pages 299-306

  Wischke, Christian ^a,b   Mathew, Simi ^a,b   Roch, Toralf ^a   Frentsch, Marco ^b   Lendlein, Andreas ^a,b  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b Berlin Brandenburg Centre for Regenerative Therapies   (Germany)

Author keywords

Adjuvant; Dendritic cell activation; NOD receptor agonist; Poly (rac lactide) co glycolide microparticle; Vaccine carrier

Indexed keywords

ADJUVANT; DENDRITIC CELLS; MICRO PARTICLES; NOD RECEPTOR AGONIST; VACCINE CARRIERS;

CELL CULTURE; CELLS; OLIGOMERIZATION; OLIGOMERS; VACCINES;

LIGANDS;

ADJUVANT; ANTIGEN; GAMMA DEXTRO GLUTAMYL MESO DIAMINOPIMELIC ACID; GLUTAMINE DERIVATIVE; MACROGOL; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; POLY[(RAC LACTIDE) CO GLYCOLIDE]; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL LINE; CONFERENCE PAPER; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG IMPURITY; ENCAPSULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; DIAMINOPIMELIC ACID; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; LIGANDS; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PARTICLE SIZE; POLYGLYCOLIC ACID; SURFACE PROPERTIES; VACCINES;

EID: 84870248834     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.06.034     Document Type: Conference Paper

References (42)

1. R. Kwok Vaccines: the real issues in vaccine safety Nature 473 7348 2011 436 438
2. R. Rappuoli, and A. Aderem A 2020 vision for vaccines against HIV, tuberculosis and malaria Nature 473 7348 2011 463 469
3. C. Foged, J. Hansen, and E.M. Agger License to kill: formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems Eur. J. Pharm. Sci. 45 4 2012 482 491
4. S. Jhunjhunwala, G. Raimondi, A.W. Thomson, and S.R. Little Delivery of rapamycin to dendritic cells using degradable microparticles J. Control. Release 133 3 2009 191 197
5. B.G. Keselowsky, C.Q. Xia, and M. Clare-Salzler Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes Hum. Vaccin. 7 1 2011 37 44
6. D.T. O'Hagan, and M. Singh S.H.E. Kaufmann, Novel Vaccination Strategies 2004 Wiley-VCH Verlag GmbH & Co. KGaA Weinheim 147 172
7. C. Wischke, and S.P. Schwendemann J. Siepmann, R.A. Siegel, M.J. Rathbone, Fundamentals and Applications of Controlled Release Drug Delivery 2011 Harwood Academic Publishers Amsterdam 171 228
8. A. Sisson, M. Schroeter, and A. Lendlein A. Lendlein, A. Sisson, Handbook of Biodegradable Polymers: Synthesis 2011 Characterisation and Applications Wiley-VCH, Weinheim 1 17
9. J.E. Babensee Interaction of dendritic cells with biomaterials Semin. Immunol. 20 2 2008 101 108
10. C. Wischke, H.-H. Borchert, J. Zimmermann, I. Siebenbrodt, and D.R. Lorenzen Stable cationic microparticles for enhanced model antigen delivery to dendritic cells J. Control. Release 114 3 2006 359 368
11. E. Walter, D. Dreher, M. Kok, L. Thiele, S.G. Kiama, P. Gehr, and H.P. Merkle Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells J. Control. Release 76 1-2 2001 149 168
12. Y. Waeckerle-Men, E. Scandella, E. Uetz-Von Allmen, B. Ludewig, S. Gillessen, H.P. Merkle, B. Gander, and M. Groettrup Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy J. Immunol. Methods 287 1-2 2004 109 124
13. A. Heit, F. Schmitz, T. Haas, D.H. Busch, and H. Wagner Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity Eur. J. Immunol. 37 8 2007 2063 2074
14. C. Schliehe, M. Thiry, U.I. Tromsdorf, J. Hentschel, H. Weller, and M. Groettrup Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy J. Control. Release 151 3 2011 278 285
15. S.G. Reed, S. Bertholet, R.N. Coler, and M. Friede New horizons in adjuvants for vaccine development Trends Immunol. 30 1 2009 23 32
16. C. Wischke, J. Zimmermann, B. Wessinger, A. Schendler, H.-H. Borchert, J.H. Peters, T. Nesselhut, and D.R. Lorenzen Poly(I:C) coated PLGA microparticles induce dendritic cell maturation Int. J. Pharm. 365 1-2 2009 61 68
17. S.P. Kasturi, I. Skountzou, R.A. Albrecht, D. Koutsonanos, T. Hua, H.I. Nakaya, R. Ravindran, S. Stewart, M. Alam, M. Kwissa, F. Villinger, N. Murthy, J. Steel, J. Jacob, R.J. Hogan, A. Garcia-Sastre, R. Compans, B. Pulendran, Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470(2011) 543-547.
18. E.J. Hennessy, A.E. Parker, and L.A. O'Neill Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9 4 2010 293 307
19. P. Neves, V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo, P. Shen, A.A. Kuhl, C. Loddenkemper, M. Haury, S.A. Nedospasov, S.H. Kaufmann, U. Steinhoff, D.P. Calado, and S. Fillatreau Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection Immunity 33 5 2010 777 790
20. M.F. Bachmann, and A. Oxenius H. Kropshofer, A.B. Vogt, Antigen presenting cells: from mechanisms to drug development 2006 Wiley-VCH Verlag GmbH & Co. KGaA Weinheim 221 237
21. Radboud University Netherlands Toll-like Receptor (TLR) ligand matured dendritic cell vaccination in melanoma patients 2009 http://clinicaltrials.gov/ ct2/show/NCT00940004
22. T.D. Kanneganti, M. Lamkanfi, and G. Nunez Intracellular NOD-like receptors in host defense and disease Immunity 27 4 2007 549 559
23. S. Benko, D.J. Philpott, and S.E. Girardin The microbial and danger signals that activate Nod-like receptors Cytokine 43 3 2008 368 373
24. G. Chen, M.H. Shaw, Y.G. Kim, and G. Nunez NOD-like receptors: role in innate immunity and inflammatory disease Annu. Rev. Pathol. 4 2009 365 398
25. P. Rosenstiel, G. Jacobs, A. Till, and S. Schreiber NOD-like receptors: ancient sentinels of the innate immune system Cell. Mol. Life Sci. 65 9 2008 1361 1377
26. W. Strober, P.J. Murray, A. Kitani, and T. Watanabe Signalling pathways and molecular interactions of NOD1 and NOD2 Nat. Rev. 6 1 2006 9 20
27. B.B. Youan, M.A. Benoit, B. Rollmann, G. Riveau, and J. Gillard Protein-loaded poly(epsilon-caprolactone) microparticles. II. Muramyl dipeptide for oral controlled release of adjuvant J. Microencapsul. 16 5 1999 601 612
28. N. Puri, J.H. Kou, and P.J. Sinko Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. I. In vitro characterization J. Control. Release 69 1 2000 53 67
29. C. Wang, P. Muttil, D. Lu, A.A. Beltran-Torres, L. Garcia-Contreras, and A.J. Hickey Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines AAPS J. 11 1 2009 139 147
30. L.A. Brito, and M. Singh Acceptable levels of endotoxin in vaccine formulations during preclinical research J. Pharm. Sci. 100 1 2011 34 37
31. S. Mathew, A. Lendlein, and C. Wischke Degradation behavior of porous copolyester microparticles in the light of dynamic changes in their morphology Macromol. Symp. 309-310 1 2011 123 133
32. C. Wischke, D. Lorenzen, J. Zimmermann, and H.H. Borchert Preparation of protein loaded poly(d, l-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer Eur. J. Pharm. Biopharm. 62 3 2006 247 253
33. M. Fountoulakis, and H.W. Lahm Hydrolysis and amino acid composition analysis of proteins J. Chromatogr. A 826 2 1998 109 134
34. M.F. Powell, L.C. Foster, A.R. Becker, and W. Lee Formulation of vaccine adjuvant muramyldipeptides (Mdp). 2. The thermal reactivity and pH of maximum stability of Mdp compounds in aqueous-solution Pharm. Res. 5 8 1988 528 532
35. T. Roch, J. Cui, K. Kratz, A. Lendlein, and F. Jung Immuno-compatibility of soft hydrophobic poly (n-butyl acrylate) networks with elastic moduli for regeneration of functional tissues Clin. Hemorheol. Microcirc. 50 1 2012 131 142
36. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, and T. Shimamoto A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid Chem. Pharm. Bull. 36 3 1988 1095 1103
37. A.M. Hafner, B. Corthesy, M. Textor, and H.P. Merkle Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling Biomaterials 32 10 2011 2651 2661
38. C. Wischke, and H.H. Borchert Influence of the primary emulsification procedure on the characteristics of small protein-loaded PLGA microparticles for antigen delivery J. Microencapsul. 23 4 2006 435 448
39. M. Kataoka, M. Ochiai, A. Yamamoto, and Y. Horiuchi A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines Biologicals 40 1 2012 49 54
40. I. Zanoni, R. Ostuni, G. Capuano, M. Collini, M. Caccia, A.E. Ronchi, M. Rocchetti, F. Mingozzi, M. Foti, G. Chirico, B. Costa, A. Zaza, P. Ricciardi-Castagnoli, and F. Granucci CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation Nature 460 7252 2009 264 268
41. H. Tada, S. Aiba, K. Shibata, T. Ohteki, and H. Takada Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells Infect. Immun. 73 12 2005 7967 7976
42. Y. Zhan, Y. Xu, S. Seah, J.L. Brady, E.M. Carrington, C. Cheers, B.A. Croker, L. Wu, J.A. Villadangos, and A.M. Lew Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways J. Immunol. 185 4 2010 2125 2133